|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 07725866.3 (espacenet) (Federated) (European Patent Register), 20070606 | | Patent/reg. no. and date | DK/EP 2027103, 20140226 | | Publication date | 20090225 | | Priority no. and date | EP 06012052, 20060612 | | EP pub. no. and date |
EP 2027103 20090225 | | Effective date | | | Applicant/owner | UCB Pharma GmbH, Alfred-Nobel-Strasse 10
40789 Monheim, DE | | Applicant ref. no. | P53864DK01 | | Inventor | MEESE, Claus, Kreuzbergerstrasse 50
40789 Monheim, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/353 (2006.01) , C07D 311/20 (2006.01) | | Title | NYT CHIRALT MELLEMPRODUKT, FREMGANGSMÅDE TIL FREMSTILLING DERAF OG DETS ANVENDELSE I FREMSTILLINGEN AF TOLTERODIN, FESOTERODIN, ELLER DEN AKTIVE METABOLIT DERAF | | Int. application no. | EP2007005008 | | Int. publication no. | WO2007144097 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
